Alemtuzumab	drug	
FCGR3B	drug_target	
C1R	drug_target	
C1QA	drug_target	
C1QB	drug_target	
C1QC	drug_target	
FCGR3A	drug_target	
FCGR1A	drug_target	
FCGR2A	drug_target	
FCGR2B	drug_target	
FCGR2C	drug_target	
CD52	drug_target	
Autoimmune hemolytic anemia	phenotype	
Natalizumab	drug	
ITGA4	drug_target	
ICAM1	drug_target	
Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	phenotype	
Rituximab	drug	
C1S	drug_target	
MS4A1	drug_target	
Aminosalicylic Acid	drug	
PTGS2	drug_target	
MPO	drug_target	
ALOX5	drug_target	
CHUK	drug_target	
PLA2G2E	drug_target	
Ipilimumab	drug	
CTLA4	drug_target	
Pegademase bovine	drug	
GRB2	drug_target	
IGHV2-5	intermediate	
CD3G	intermediate	
NFKB2	intermediate	
NFKB1	intermediate	
CD19	intermediate	
WAS	intermediate	
TFRC	intermediate	
WIPF1	intermediate	
NRAS	intermediate	
SPTB	intermediate	
SPTA1	intermediate	
ICOS	intermediate	
IL2RA	intermediate	
